A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Effects of 3 Years of Treatment with a Selective Estrogen Receptor Modulator for Postmenopausal Osteoporosis on Markers of Bone Turnover and Bone Mineral Density
2012
The Showa University Journal of Medical Sciences
Aim : The aim of the present study was to assess the changes in bone mineral density and bone turnover markers in long-term SERM. Methods : The study was performed on 25 female outpatients with primary osteoporosis treated at the Osteoporosis Department of Showa University School of Medicine. All patients had been on raloxifene 60 mg/day for ≥ 3 years. The mean patient age was 67.1 years and the women were, on average, 18.4 years postmenopausal. Levels of bone turnover markers urinary
doi:10.15369/sujms.24.301
fatcat:o7mbt5oembfp5bnodhmn2r2miu